India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to ...

Certain foods can worsen GI side effects from GLP-1 durgs. Learn which foods to avoid and which to choose instead.

Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...

FAYETTEVILLE, Ark. — As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming less processed foods and soda, researchers say food and ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy will have the ... TODAY Daily Crossword Puzzle. The Food and Drug Administration allows ...

As the FDA has recently removed semaglutide and tirzepatide—the two drugs used in Wegovy and Zepbound, respectively—off its drug shortage list, GLP-1 compounders have sued the FDA, claiming ...

Obesity “wonder drug” Wegovy is expected to be on sale in Ireland in the next 10 days but, even now, the woman charged with overseeing new product launches of the drug’s developer ...

Compounding pharmacies have been selling hundreds of thousands of doses of copies of Wegovy while it was in shortage. The Food and Drug Administration has since asked them to cease making copies ...